An Investigation of the Metabolism and Excretion of KD101 and Its Interindividual Differences: A Microtracing Mass Balance Study in Humans

The absorption, metabolism, and excretion (AME) profiles of KD101, currently under clinical development to treat obesity, were assessed in humans using accelerator mass spectrometry (AMS) after a single oral administration of KD101 at 400 mg and a microdose of (14)C‐KD101 at ~ 35.2 μg with a total r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Anhye, Dueker, Stephen R., Hwang, Jun Gi, Yoon, Jangsoo, Lee, Sang‐Won, Lee, Hye Suk, Yu, Byung‐Yong, Yu, Kyung‐Sang, Lee, Howard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877834/
https://www.ncbi.nlm.nih.gov/pubmed/33460293
http://dx.doi.org/10.1111/cts.12848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877834/
https://www.ncbi.nlm.nih.gov/pubmed/33460293
http://dx.doi.org/10.1111/cts.12848

Ejemplares similares